1IA
ELV icon

1620 Investment Advisors’s Elevance Health ELV Stock Holding History

1620 Investment Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$1.25K – 715
2024
Q3 		$1.25K Buy
+2
New +$1.07K ﹤0.01% 600

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

1620 Investment Advisors's ELV Position: Q4 2024 in Review

1620 Investment Advisors sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 2 shares — an estimated $1.25K sold.

1620 Investment Advisors first reported a position in ELV in Q3 2024 and held it in 1 quarter. The position peaked at $1.25K in Q3 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • 1620 Investment Advisors reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • 1620 Investment Advisors sold 2 Elevance Health shares in Q4 2024, an estimated $1.25K.
  • 1620 Investment Advisors first reported a position in Elevance Health in Q3 2024 and held it in 1 quarter.
  • 1620 Investment Advisors's Elevance Health position peaked at $1.25K in Q3 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on 1620 Investment Advisors's 13F filing for Q4 2024, filed 11 Feb 2025.